Eric J Lawitz
4PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.Stuart C Gordon, Alejandra Villamil, Ira M Jacobson
|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.Cynthia Levy, Palak J Trivedi, Kris V Kowdley
|Oct 27, 2023
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study.Eric J Lawitz, Thomas Reiberger, Jörn M Schattenberg
|Jun 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein
Pageof 1
Frequent Collaborators
3 joint publications
John M Vierling
3 joint publications
Cynthia Levy
3 joint publications
Christopher L Bowlus
2 joint publications
Christophe Corpechot
2 joint publications
Joost P H Drenth
2 joint publications
Kris V Kowdley
2 joint publications
Andreas E Kremer
2 joint publications
George N Dalekos
2 joint publications
Marlyn J Mayo
2 joint publications
Stuart C Gordon
